ISSN 2330-717X


Electron micrograph of an Ebola virus virion. Photo created by CDC microbiologist Cynthia Goldsmith, Wikipedia Commons.

Ebola Vaccine: Promising Phase I Trials

“The results for tolerability, safety, and the immune response to the vaccine candidate are very promising,” according to Prof. Marylyn Addo. The antibodies which developed against the virus were still detectable after six months. Addo…

Eurasia Review Needs Your Help!

It's that simple. We have no financial backing, and are not supported by any institution, corporation or organization.


We are truly an independent news organization dedicated to providing a publishing venue for alternative, global views, news and analysis.


Furthermore, we are entirely self-financed, and yet our costs continue to increase.


If you enjoy reading Eurasia Review please consider donating today to ensure that we are able to provide our service. We thank you in advance.